Actively Recruiting

Phase 1
Age: 50Years +
All Genders
ID07543861

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

Led by University of Michigan · Updated on 2026-04-22

5

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a new type of dynamic standing desk for people with Parkinson's disease to understand how it affects walking and movement. This pilot study focuses on the user experience by comparing dynamic standing to static standing and sitting. The research is conducted in two phases, with this being phase 1, an open-label study designed to gather initial data on gait function improvement. Participants will attend up to twelve 4-hour sessions using the dynamic standing desk over a six-week period. During each session, the desk moves to encourage small steps while standing, and participants may take breaks as needed. Baseline clinical assessments will be done before starting the sessions, and outcome assessments will be repeated after the intervention period to measure changes. Throughout the study, participants will undergo various tests including gait speed, movement disorder rating scales, cognitive assessments, and functional mobility tests such as Timed Up and Go and 5 Times Sit to Stand. All sessions and assessments must be completed within six weeks, with a total of up to fourteen visits including baseline and outcome evaluations. This study is sponsored by the University of Michigan and focuses on collecting detailed clinical measurements to evaluate the desk's impact on Parkinson's symptoms.

CONDITIONS

Brief Title

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Parkinson's Disease
Not Eligible

You will not qualify if you...

  • Inability to stand or walk without an assistive device
  • History of symptoms in stance that preclude safe and comfortable participation, such as dizziness and lightheadedness, orthostasis, severe symptomatic leg or back musculoskeletal pain, or medication side effects
  • Any other history of medical or psychiatric comorbidity, precluding safe participation in the project
  • History of symptomatic cardiovascular or pulmonary disease
  • History of active rheumatic arthritis
  • History of stroke or other neurologic conditions with significant residual sensorimotor deficits
  • History of disabling chronic pain syndrome requiring narcotic analgesics
  • Evidence of dementia (Mini Mental State Exam or Montreal Cognitive Assessment test <24 and significant impairment in activities of daily living)
  • Venous ulcerative stasis or severe varicosities
  • Pregnancy as determined by urine pregnancy test prior to DXA procedure in women of childbearing potential

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Screening and enrollment visit

Implementation

Duration - Up to 6 weeks

Participants use the dynamic standing desk during sessions where the desk moves to prompt small steps while standing for up to 4 hours per session.

Up to 12 sessions, each lasting 4 hours

Follow-up

Duration - Within 6 weeks after baseline

Participants undergo outcome assessments repeating clinical measurements collected at baseline to evaluate changes after the intervention.

1 outcome session

Trial Site Locations

Total: 1 location

1

Domino's Farms

Ann Arbor, Michigan, United States, 48105

Actively Recruiting

Loading map...

Research Team

M

Miriam Van Emde Boas, DPT

C

Chatkaew Pongmala, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

10,000 STEP CLUB: Community Walking Program to Decrease Sede...

Parkinson Disease

Actively Recruiting

1 location

18F-DOPA II - PET Imaging Optimization

Congenital Hyperinsulinism

Actively Recruiting

1 location

24-month Open-label Study to Evaluate Safety, Tolerability, ...

Parkinson Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here